Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hardware Heister who wrote (103)	5/9/1998 5:29:00 PM
From: 5,17,37,5,101,...	Read Replies (1) of 2515

You're right; what can I say except that things look too good. IMCL has some excellent drugs that are near approval. The C225 is probably worth, ball park, $200 to $300 million or more depending on the number of tumors upon which it works -- that's $8.00/share. The BEC2 drug is probably worth about the same if it really works. So that adds up to $14 to $16. The rest of the research efforts probably are worth around $4 to $5, especially given success with BEC2 and C225 because management will have shown that it can follow through. So that adds up to $18 or $20. Add a couple of dollars for the bubble cancer craze and the momentum players, and suddenly the stock goes to $30 ... oops, Monday looks like a down day just because I said that. Jackson

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next